Expansion of human megakaryocyte-biased hematopoietic stem cells by biomimetic Microniche.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
18 04 2023
Historique:
received: 14 11 2022
accepted: 04 04 2023
medline: 20 4 2023
pubmed: 19 4 2023
entrez: 18 04 2023
Statut: epublish

Résumé

Limited numbers of available hematopoietic stem cells (HSCs) limit the widespread use of HSC-based therapies. Expansion systems for functional heterogenous HSCs remain to be optimized. Here, we present a convenient strategy for human HSC expansion based on a biomimetic Microniche. After demonstrating the expansion of HSC from different sources, we find that our Microniche-based system expands the therapeutically attractive megakaryocyte-biased HSC. We demonstrate scalable HSC expansion by applying this strategy in a stirred bioreactor. Moreover, we identify that the functional human megakaryocyte-biased HSCs are enriched in the CD34

Identifiants

pubmed: 37072407
doi: 10.1038/s41467-023-37954-3
pii: 10.1038/s41467-023-37954-3
pmc: PMC10113370
doi:

Substances chimiques

Antigens, CD34 0
Leukocyte Common Antigens EC 3.1.3.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2207

Informations de copyright

© 2023. The Author(s).

Références

Biophys J. 2020 Aug 4;119(3):502-513
pubmed: 32668233
Nature. 2019 May;569(7755):222-228
pubmed: 30971824
Nat Mater. 2017 Dec;16(12):1252-1261
pubmed: 29170554
Nat Rev Immunol. 2015 Jan;15(1):7-17
pubmed: 25534619
Cell Stem Cell. 2021 Mar 4;28(3):535-549.e8
pubmed: 33340451
Cell Stem Cell. 2020 Apr 2;26(4):527-541.e8
pubmed: 32197066
Cell Stem Cell. 2015 Oct 1;17(4):422-34
pubmed: 26299573
J Immunol Methods. 2009 Aug 15;347(1-2):70-8
pubmed: 19567251
Lancet Haematol. 2020 Feb;7(2):e134-e145
pubmed: 31704264
Nature. 2018 Nov;563(7731):347-353
pubmed: 30429548
Nat Rev Mol Cell Biol. 2017 Dec;18(12):728-742
pubmed: 29115301
Science. 2011 Jul 8;333(6039):218-21
pubmed: 21737740
JAMA Oncol. 2015 May;1(2):249-51
pubmed: 26181032
Science. 2014 Sep 19;345(6203):1509-12
pubmed: 25237102
Nature. 2010 Aug 12;466(7308):829-34
pubmed: 20703299
Nature. 2013 Oct 10;502(7470):232-6
pubmed: 23934107
Cell Stem Cell. 2016 Jan 7;18(1):144-55
pubmed: 26669897
Front Pharmacol. 2015 Jan 12;5:278
pubmed: 25628564
Nature. 2014 Jan 16;505(7483):327-34
pubmed: 24429631
Sci Adv. 2021 Jul 2;7(27):
pubmed: 34215590
Blood. 2019 Mar 28;133(13):1427-1435
pubmed: 30728145
J Mech Behav Biomed Mater. 2015 Oct;50:299-307
pubmed: 26189198
Science. 2022 Jun 3;376(6597):eabo0510
pubmed: 35549310
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Nat Commun. 2018 Jun 28;9(1):2532
pubmed: 29955044
Blood. 2013 Oct 24;122(17):3074-81
pubmed: 23996087
Nucleic Acids Res. 2019 Jan 8;47(D1):D721-D728
pubmed: 30289549
Nature. 2019 Jul;571(7763):117-121
pubmed: 31142833
Nat Rev Genet. 2020 Sep;21(9):541-554
pubmed: 32467607
Haematologica. 2019 Oct;104(10):1950-1961
pubmed: 30792200
N Engl J Med. 2018 Oct 25;379(17):1643-1656
pubmed: 30354958
Cell Stem Cell. 2019 Mar 7;24(3):405-418.e7
pubmed: 30849366
Blood. 2021 Oct 7;138(14):1211-1224
pubmed: 34115843
Tissue Eng Part C Methods. 2020 May;26(5):263-275
pubmed: 32268824
F1000Res. 2019 Oct 31;8:
pubmed: 31723413
Nature. 2018 Feb 1;554(7690):106-111
pubmed: 29298288
Science. 2016 Jan 8;351(6269):aab2116
pubmed: 26541609
Adv Sci (Weinh). 2021 Aug;8(15):e2100921
pubmed: 34042332
N Engl J Med. 2012 Jul 5;367(1):11-9
pubmed: 22762314
Blood. 2014 Oct 30;124(18):2775-83
pubmed: 25237198
Blood. 2006 Feb 15;107(4):1366-74
pubmed: 16234354
Cell Stem Cell. 2012 Feb 3;10(2):120-36
pubmed: 22305562
Science. 2010 Sep 10;329(5997):1345-8
pubmed: 20688981
N Engl J Med. 2017 Jun 1;376(22):2168-2181
pubmed: 28564565
Blood. 2016 Dec 22;128(25):2988-2999
pubmed: 27769957
Nature. 2020 Feb;578(7794):278-283
pubmed: 32025033
Blood Adv. 2021 Mar 9;5(5):1250-1258
pubmed: 33646303
Nat Biotechnol. 2017 Dec;35(12):1202-1210
pubmed: 29131149
Br J Haematol. 2018 Mar;180(6):863-878
pubmed: 29392716
Tissue Eng Part A. 2021 Feb;27(3-4):223-236
pubmed: 32539550
Nanomedicine. 2018 Jul;14(5):1707-1718
pubmed: 29753127
Nature. 2018 Jan 11;553(7687):212-216
pubmed: 29323290
Nat Med. 2019 Oct;25(10):1566-1575
pubmed: 31591594
Nat Med. 2012 Dec;18(12):1778-85
pubmed: 23142822
Cell Stem Cell. 2018 May 3;22(5):627-638
pubmed: 29727678
Biomaterials. 2019 Mar;196:67-79
pubmed: 29602560
Nature. 2017 May 25;545(7655):432-438
pubmed: 28514439

Auteurs

Yinghui Li (Y)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Mei He (M)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Wenshan Zhang (W)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Wei Liu (W)

Department of Biomedical Engineering, School of Medicine, Tsinghua-PKU Center for Life Sciences, Tsinghua University, 100084, Beijing, China.
Beijing CytoNiche Biotechnology Co. Ltd., 100195, Beijing, China.

Hui Xu (H)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Ming Yang (M)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Hexiao Zhang (H)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Haiwei Liang (H)

Department of Biomedical Engineering, School of Medicine, Tsinghua-PKU Center for Life Sciences, Tsinghua University, 100084, Beijing, China.

Wenjing Li (W)

Department of Biomedical Engineering, School of Medicine, Tsinghua-PKU Center for Life Sciences, Tsinghua University, 100084, Beijing, China.

Zhaozhao Wu (Z)

Department of Biomedical Engineering, School of Medicine, Tsinghua-PKU Center for Life Sciences, Tsinghua University, 100084, Beijing, China.

Weichao Fu (W)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Shiqi Xu (S)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Xiaolei Liu (X)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Sibin Fan (S)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Liwei Zhou (L)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Chaoqun Wang (C)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Lele Zhang (L)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Yafang Li (Y)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Jiali Gu (J)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Jingjing Yin (J)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Yiran Zhang (Y)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Yonghui Xia (Y)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Tianjin Institutes of Health Science, Tianjin, 301600, China.

Xuemei Mao (X)

Nankai Hospital, Tianjin Hospital of Integrated Traditional Chinese and Western Medicine, Tianjin, 300100, China.

Tao Cheng (T)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. chengtao@ihcams.ac.cn.
Tianjin Institutes of Health Science, Tianjin, 301600, China. chengtao@ihcams.ac.cn.

Jun Shi (J)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. shijun@ihcams.ac.cn.
Tianjin Institutes of Health Science, Tianjin, 301600, China. shijun@ihcams.ac.cn.

Yanan Du (Y)

Department of Biomedical Engineering, School of Medicine, Tsinghua-PKU Center for Life Sciences, Tsinghua University, 100084, Beijing, China. duyanan@tsinghua.edu.cn.
Beijing CytoNiche Biotechnology Co. Ltd., 100195, Beijing, China. duyanan@tsinghua.edu.cn.

Yingdai Gao (Y)

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, PUMC Department of Stem Cell and Regenerative Medicine, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. ydgao@ihcams.ac.cn.
Tianjin Institutes of Health Science, Tianjin, 301600, China. ydgao@ihcams.ac.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH